Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
ExpressionEdits logo — building biology like nature

ExpressionEdits

building biology like nature

Founded 2021 United Kingdom Cambridge, United Kingdom 25 employees Seed Total: $13.00M AI, Biotechnology

General Information

Company Name ExpressionEdits
Founded Year 2021
Location United Kingdom Cambridge, United Kingdom
Employees 25
Industries AI, Biotechnology
Funding Stage Seed
Business Model B2B, SaaS, Platform
Revenue Model Licensing, Service Fee, Subscription
Social

BounceWatch is an independent company data service, not affiliated with ExpressionEdits. To contact ExpressionEdits, visit expressionedits.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ExpressionEdits compare?

A PDF of ExpressionEdits and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ExpressionEdits soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ExpressionEdits

ExpressionEdits, founded in 2021, is a promising startup in the AI and Biotechnology industries. Headquartered in the United Kingdom, the company is fundamentally redefining genetic design with its slogan, "building biology like nature."

By focusing on the precise application of genetic grammar in transgenic design, ExpressionEdits is enabling the creation of previously inaccessible proteins. Their innovative approach is encapsulated in their description: "Getting genetic syntax right," which positions them as a pioneering force in genetic technology.

The company's robust potential attracted a $13.00M Seed Round investment on 29 May 2024. This round was led by notable investors including Blue Yard Capital, Octopus Ventures, Redalpine, Wilbe | Home for Scientist Leaders, Amino Collective, Acequia Capital (AceCap), and Hawktail Management. This diverse group of backers underscores the strong confidence in ExpressionEdits' groundbreaking technological innovations.

Business keywords: Genetic Engineering, Synthetic Biology, Protein Expression, Transgenic Design, Genetic Grammar, Synthetic DNA, AI-driven Approach, Healthcare Proteins, Biology Innovation, Biotech Advancements, DNA Redesign, Protein Design

Services & Products

Development of enhanced gene therapies
Protein expression optimization
Genetic Syntax Engine for transgene design

Target Customers

Biotech companies Pharmaceutical companies Research institutions Healthcare providers

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed $13.00M 7
Blue Yard Capital Octopus Ventures Acequia Capital
Blue Yard Capital, Octopus Ventures +5
01 May 2024
Seed Undisclosed 1
Wilbe | Home for Scientist Leaders
Wilbe | Home for Scientist Leaders
01 Jan 2022
Spinout Undisclosed 2
Cambridge Enterprise The University of Cambridge
Cambridge Enterprise, The University of Cambridge
01 Jan 2021

Latest News

View All
From labs to market: 10 promising biotech startups based in the UK — Eu-startups
From labs to market: 10 promising biotech startups based in the UK
Eu-startups Aug 01, 2024

ExpressionEdits Alternatives & Competitors

View All Alternatives
ExpressionEdits vs
Profluent
Profluent United States

Grounded in nature, authored by AI

Venture round
83 employees
AI, Biotechnology
Compare ExpressionEdits vs Profluent
ExpressionEdits vs
Basecamp Research
Basecamp Research United Kingdom

Basecamp Research trains frontier AI models for therapeutic design.

Series C
76 employees
AI, Biotechnology
Compare ExpressionEdits vs Basecamp Research
ExpressionEdits vs
Asimov
Asimov United States

Intelligent design of living systems

Series B
120 employees
AI, Biotechnology
View all alternatives

FAQ About ExpressionEdits

building biology like nature
ExpressionEdits was founded in 2021.
ExpressionEdits is headquartered in Cambridge, United Kingdom.
ExpressionEdits operates in AI and Biotechnology. Its work centres on Genetic Engineering, Synthetic Biology, Protein Expression and Transgenic Design. Its customers include Biotech companies, Pharmaceutical companies and Research institutions.
ExpressionEdits has a B2B, SaaS and Platform business model. Its revenue comes from Licensing, Service Fee and Subscription.
ExpressionEdits has approximately 25 employees.
ExpressionEdits has completed 3 funding rounds, raising a total of $13.00M. The latest funding stage is Seed.
ExpressionEdits offers: Development of enhanced gene therapies, Protein expression optimization, Genetic Syntax Engine for transgene design.
Top alternatives and competitors to ExpressionEdits include Profluent, Basecamp Research, Asimov, Cradle, Absci. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ExpressionEdits and Profluent are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ExpressionEdits, https://bouncewatch.com/company/expressionedits, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout